From January 1, 2024 to March 31, 2024, the company has repurchased 329,790 shares, representing 0.17% for CNY 10 million. With this, the company has completed the repurchase of 836,090 shares, representing 0.42% for CNY 30.03 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.09 CNY | -1.39% |
|
-7.15% | -25.92% |
06-07 | PharmaBlock Sciences, Inc. Announces Dividend on Share A for the Year 2023, Payable on June 14, 2024 | CI |
05-20 | PharmaBlock Sciences, Inc. Approves Cash Dividend for the Year 2023 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.92% | 798M | |
+47.33% | 765B | |
-6.76% | 354B | |
+19.48% | 331B | |
+8.69% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+4.78% | 164B | |
-2.47% | 162B |
- Stock Market
- Equities
- 300725 Stock
- News PharmaBlock Sciences (Nanjing), Inc.
- Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.